$0.25
+0.00 (+0.00%)
USD · as of 2026-08-19 · marketstack
Clinical trials
catalyst calendar across sponsors →Studies where ATXI is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
3 interventional · 2 with posted results
Held by 0 tracked-famous managers · FINRA short interest 1.0 days to cover (settled 2026-07-31) · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|---|
| Tramadol Versus Placebo and Morphine in the Management of Post-Operative Pain AbdominoplastyNCT03774836The Sum of Pain Intensity Differences through 24 hoursRandomized · Triple-masked · Treatment | Phase 3 | Active, not recruiting | Drug: Tramadol, Morphine · Other: Placebo | Pain Management | 360 | 2019-05-30 | 2019-05-09 |
| Evaluate Safety of Tramadol in the Management of Postoperative Pain Following SurgeryNCT03395808results2021-03-09Adverse EventsOpen-label · OtherStudy Protocol ↗ · Statistical Analysis Plan ↗ | Phase 3 | Completed | Drug: Tramadol | Pain Management | 251 | 2019-04-25actual | 2021-03-09 |
| Tramadol Versus Placebo in the Management of Postoperative Pain Following BunionectomyNCT03290378results2020-03-19The Sum of Pain Intensity Differences (SPID) Through 48 Hours Post First DoseRandomized · Triple-masked · TreatmentStudy Protocol and Statistical Analysis Plan ↗ | Phase 3 | Completed | Drug: Tramadol · Other: Placebo | Pain Management | 409 | 2018-04-11actual | 2020-03-19 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19